DE60329700D1 - Glycoproteinsynthese - Google Patents

Glycoproteinsynthese

Info

Publication number
DE60329700D1
DE60329700D1 DE60329700T DE60329700T DE60329700D1 DE 60329700 D1 DE60329700 D1 DE 60329700D1 DE 60329700 T DE60329700 T DE 60329700T DE 60329700 T DE60329700 T DE 60329700T DE 60329700 D1 DE60329700 D1 DE 60329700D1
Authority
DE
Germany
Prior art keywords
amino acid
unnatural amino
protein
methods
method involves
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60329700T
Other languages
English (en)
Inventor
Peter G Schultz
Lei Wang
Zhiwen Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Application granted granted Critical
Publication of DE60329700D1 publication Critical patent/DE60329700D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE60329700T 2002-10-16 2003-10-15 Glycoproteinsynthese Expired - Lifetime DE60329700D1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US41926502P 2002-10-16 2002-10-16
US42099002P 2002-10-23 2002-10-23
US44145003P 2003-01-16 2003-01-16
PCT/US2003/032870 WO2004035605A2 (en) 2002-10-16 2003-10-15 Glycoprotein synthesis

Publications (1)

Publication Number Publication Date
DE60329700D1 true DE60329700D1 (en) 2009-11-26

Family

ID=32110831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60329700T Expired - Lifetime DE60329700D1 (en) 2002-10-16 2003-10-15 Glycoproteinsynthese

Country Status (14)

Country Link
US (11) US6927042B2 (de)
EP (1) EP1558747B1 (de)
JP (1) JP4752001B2 (de)
KR (1) KR20050073559A (de)
AT (1) ATE445709T1 (de)
AU (1) AU2003286436B2 (de)
CA (1) CA2500653A1 (de)
DE (1) DE60329700D1 (de)
ES (1) ES2333422T3 (de)
HK (1) HK1074855A1 (de)
IL (6) IL196906A0 (de)
MX (1) MXPA05003978A (de)
SG (1) SG160203A1 (de)
WO (1) WO2004035605A2 (de)

Families Citing this family (103)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005502322A (ja) * 2001-04-19 2005-01-27 ザ スクリップス リサーチ インスティテュート 非天然アミノ酸のインビボ組込み
US8414774B2 (en) * 2001-04-25 2013-04-09 Agilent Technologies, Inc. Systems and methods for high-throughput screening of fluidic samples
WO2009059286A1 (en) * 2007-11-02 2009-05-07 Biotrove, Inc. Devices and methods for coupling mass spectrometry devices with chromatography systems
US20050123970A1 (en) * 2001-04-25 2005-06-09 Can Ozbal High throughput autosampler
DE60327369D1 (de) 2002-10-16 2009-06-04 Scripps Research Inst Stellenspezifischer einbau von ketoaminosäuren in proteine
KR20050073559A (ko) 2002-10-16 2005-07-14 더 스크립스 리서치 인스티튜트 당단백질 합성
US7618775B2 (en) * 2003-04-17 2009-11-17 The Scripps Research Institute Expanding the eukaryotic genetic code
EP1636340A4 (de) 2003-06-18 2009-02-11 Scripps Research Inst Ergänzungen zum genetischen code von unnatürlichen reaktiven aminosäuren
EP1704242A4 (de) * 2003-07-07 2008-06-18 Scripps Research Inst ZUSAMMENSETZUNGEN MIT PAAREN VON ORTHOGONALER LEUCYL-tRNA UND AMINOACYL-tRNA-SYNTHETASE UND VERWENDUNGEN DAVON
EP1658366A4 (de) 2003-07-07 2006-08-09 Scripps Research Inst Zusammensetzungen von orthogonalen glutamyl-trna- und aminoacyl-trna-synthetasepaaren und deren verwendungen
PT1914314E (pt) 2003-07-07 2010-09-08 Scripps Research Inst Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações
JP5657850B2 (ja) 2003-10-14 2015-01-21 ザ スクリプス リサーチ インスティテュート 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ
MXPA06008496A (es) 2004-02-02 2007-01-30 Ambrx Inc Polipeptidos de interferon humano modificados y sus usos.
US20050260711A1 (en) * 2004-03-30 2005-11-24 Deepshikha Datta Modulating pH-sensitive binding using non-natural amino acids
US20050287639A1 (en) * 2004-05-17 2005-12-29 California Institute Of Technology Methods of incorporating amino acid analogs into proteins
BRPI0511482A (pt) * 2004-05-25 2007-12-26 Scripps Research Inst incorporação sìtio-especìfica de aminoácidos artificiais contendo átomos pesados em proteìnas para determinação de estrutura cristalina
MXPA06014684A (es) 2004-06-18 2007-02-12 Ambrx Inc Novedosos polipeptidos de enlace antigeno y sus usos.
KR20070039593A (ko) * 2004-07-21 2007-04-12 암브룩스, 인코포레이티드 비천연적으로 코딩된 아미노산을 이용한 생합성 폴리펩티드
WO2009100255A2 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
WO2006034410A2 (en) * 2004-09-21 2006-03-30 The Scripps Resarch Institute Adding photoregulated amino acids to the genetic code
US7718410B2 (en) * 2004-09-21 2010-05-18 The Scripps Research Institute In vivo incorporation of alkynyl amino acids into proteins in eubacteria
WO2006036779A2 (en) * 2004-09-22 2006-04-06 The Scripps Research Institute Site-specific labeling of proteins for nmr studies
US20080064059A1 (en) * 2004-10-20 2008-03-13 Scripps Research Institute In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria
BRPI0517381A (pt) 2004-10-27 2008-10-07 Scripps Research Inst componentes ortogonais de tradução para a incorporação in vivo de aminoácidos não naturais
EP1814573B1 (de) 2004-10-29 2016-03-09 ratiopharm GmbH Remodellierung und glykopegylierung von fibroblasten-wachstumsfaktor (fgf)
ATE541934T1 (de) 2004-12-22 2012-02-15 Ambrx Inc Zusammensetzungen von aminoacyl-trna-synthetase und verwendungen davon
BRPI0518661A2 (pt) 2004-12-22 2008-12-02 Ambrx Inc mÉtodos para expressço e purificaÇço do hormânio do crescimento humano recombinante
MX2007007580A (es) * 2004-12-22 2007-12-11 Ambrx Inc Hormona del crecimiento humana modificada.
KR101224781B1 (ko) 2004-12-22 2013-01-21 암브룩스, 인코포레이티드 비천연적으로 코딩된 아미노산을 포함하는 인간 성장호르몬의 조제물
EP1893229B1 (de) 2005-06-03 2011-10-19 Ambrx, Inc. Verbesserte humane interferon-moleküle und ihre verwendungen
KR20080069993A (ko) * 2005-10-12 2008-07-29 더 스크립스 리서치 인스티튜트 파지-디스플레이된 폴리펩티드의 선별적인 번역후 변형
PT2339014E (pt) * 2005-11-16 2015-10-13 Ambrx Inc Métodos e composições compreendendo aminoácidos não-naturais
US7776535B2 (en) * 2006-02-06 2010-08-17 Franklin And Marshall College Site-specific incorporation of fluorinated amino acids into proteins
PL1999259T3 (pl) 2006-03-03 2015-01-30 California Inst Of Techn Specyficzne miejscowo wprowadzanie aminokwasów do cząsteczek
JP5589186B2 (ja) * 2006-03-09 2014-09-17 ザ スクリプス リサーチ インスティテュート 真正細菌宿主細胞における直交翻訳成分の発現システム
US8217145B2 (en) 2006-03-16 2012-07-10 The Scrips Research Institute Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
US7632492B2 (en) 2006-05-02 2009-12-15 Allozyne, Inc. Modified human interferon-β polypeptides
WO2007139870A1 (en) * 2006-05-23 2007-12-06 The Scripps Research Institute Genetically encoded fluorescent coumarin amino acids
CN106008699A (zh) 2006-09-08 2016-10-12 Ambrx公司 经修饰的人类血浆多肽或Fc骨架和其用途
US8420792B2 (en) 2006-09-08 2013-04-16 Ambrx, Inc. Suppressor tRNA transcription in vertebrate cells
CA2662753C (en) 2006-09-08 2016-02-23 Ambrx, Inc. Hybrid suppressor trna for vertebrate cells
MX2009002987A (es) * 2006-09-21 2009-04-28 Scripps Research Inst Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias.
JP2010506591A (ja) 2006-10-18 2010-03-04 ザ スクリップス リサーチ インスティテュート 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み
US7403686B1 (en) * 2006-11-30 2008-07-22 The United States Of America As Represented By The Secretary Of The Navy Fiber optic cable splicing technique
WO2008103618A1 (en) * 2007-02-22 2008-08-28 University Of Utah Research Foundation Synthesis of novel xylosides and potential uses thereof
EP2068909B1 (de) 2007-03-30 2012-04-25 Ambrx, Inc. Modifizierte fgf-21 polypeptide und ihre verwendung
AU2008247815B2 (en) 2007-05-02 2012-09-06 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
AU2008316796A1 (en) 2007-10-25 2009-04-30 Massachusetts Institute Of Technology Genetic incorporation of 3-aminotyrosine into reductases
FR2922769A1 (fr) * 2007-10-31 2009-05-01 Halina Malina Modification des sequences intrinsequement desordonnees pour la preparation de vaccins
US20090148887A1 (en) * 2007-11-02 2009-06-11 The Scripps Research Institute Genetically encoded boronate amino acid
AU2008325239A1 (en) 2007-11-02 2009-05-14 The Scripps Research Institute Directed evolution using proteins comprising unnatural amino acids
JP5547083B2 (ja) 2007-11-20 2014-07-09 アンブルックス，インコーポレイテッド 修飾されたインスリンポリペプチドおよびそれらの使用
AU2008335778B2 (en) * 2007-12-11 2014-04-10 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast Pichia pastoris
CN101960017B (zh) 2008-01-03 2017-06-09 康乃尔研究基金会有限公司 原核生物中的糖基化蛋白表达
CA2712080A1 (en) * 2008-02-08 2009-08-13 The Scripps Research Institute Breaking immunological tolerance with a genetically encoded unnatural amino acid
WO2009151491A2 (en) * 2008-02-27 2009-12-17 The Scripps Research Institute In vivo incorporation of an unnatural amino acid comprising a 1,2-aminothiol group
US9296810B2 (en) 2008-05-02 2016-03-29 Novartis Ag Fibronectin-based binding molecules and uses thereof
US10138283B2 (en) 2008-07-23 2018-11-27 Ambrx, Inc. Modified bovine G-CSF polypeptides and their uses
CN107022020A (zh) 2008-09-26 2017-08-08 Ambrx公司 修饰的动物促红细胞生成素多肽和其用途
MX348657B (es) 2008-09-26 2017-06-21 Ambrx Inc Microorganismos y vacunas dependientes de replicacion de aminoacidos no naturales.
US20090197339A1 (en) * 2008-12-10 2009-08-06 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris
CN102307905B (zh) 2008-12-10 2015-11-25 斯克利普斯研究院 利用化学反应性非天然氨基酸产生载体-肽偶联物
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
JP6091892B2 (ja) * 2009-06-16 2017-03-08 グライセラ・リミテッド グリコシル化に関連する物質および方法
WO2011051327A2 (en) 2009-10-30 2011-05-05 Novartis Ag Small antibody-like single chain proteins
WO2011051466A1 (en) 2009-11-02 2011-05-05 Novartis Ag Anti-idiotypic fibronectin-based binding molecules and uses thereof
CA2784800A1 (en) 2009-12-21 2011-07-21 Ambrx, Inc. Modified porcine somatotropin polypeptides and their uses
AU2010341516B2 (en) 2009-12-21 2014-01-16 Ambrx, Inc. Modified bovine somatotropin polypeptides and their uses
WO2011092233A1 (en) 2010-01-29 2011-08-04 Novartis Ag Yeast mating to produce high-affinity combinations of fibronectin-based binders
US9567386B2 (en) 2010-08-17 2017-02-14 Ambrx, Inc. Therapeutic uses of modified relaxin polypeptides
SG10201506443TA (en) 2010-08-17 2015-10-29 Ambrx Inc Modified relaxin polypeptides and their uses
CN103261222B (zh) 2010-09-10 2017-07-28 医疗免疫有限公司 抗体衍生物
AR083006A1 (es) 2010-09-23 2013-01-23 Lilly Co Eli Formulaciones para el factor estimulante de colonias de granulocitos (g-csf) bovino y variantes de las mismas
JP6162606B2 (ja) 2011-01-14 2017-07-12 レッドウッド バイオサイエンス， インコーポレイテッド アルデヒド−タグ付き免疫グロブリンポリペプチド及びその使用方法
SG10201702387YA (en) 2012-09-24 2017-04-27 Medimmune Ltd Cell lines
CN102946253B (zh) * 2012-10-23 2016-06-08 保定市三川电气有限责任公司 数据采样方法与系统及其在参数辨识中的应用方法与系统
JO3564B1 (ar) 2013-03-08 2020-07-05 Novartis Ag ببتيدات وتركيبات لعلاج ضرر المفاصل
CN112851766A (zh) 2013-03-13 2021-05-28 美国政府(由卫生和人类服务部的部长所代表) 融合前rsv f蛋白和其用途
EP2855533A4 (de) 2013-03-15 2015-11-25 Momenta Pharmaceuticals Inc Verfahren in zusammenhang mit ctla4-fc-fusionsproteinen
ES2708759T3 (es) 2013-05-13 2019-04-11 Momenta Pharmaceuticals Inc Procedimientos para el tratamiento de la neurodegeneración
EP3021942A4 (de) 2013-07-19 2017-04-19 The Regents of The University of California Epidermaler wachstumsfaktor 8 in form von milchfettkügelchen zur fettsäureaufnahmeregulierung
WO2015057622A1 (en) 2013-10-16 2015-04-23 Momenta Pharmaceuticals, Inc. Sialylated glycoproteins
US11504346B2 (en) 2013-11-03 2022-11-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Redox-activated pro-chelators
WO2015120287A2 (en) * 2014-02-06 2015-08-13 Yale University Compositions and methods of use thereof for making polypeptides with many instances of nonstandard amino acids
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
LT3412302T (lt) 2014-10-24 2021-07-26 Bristol-Myers Squibb Company Modifikuoti fgf-21 polipeptidai ir jų panaudojimai
WO2017189432A1 (en) 2016-04-26 2017-11-02 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
CN106316920B (zh) * 2016-07-23 2018-12-04 常州大学 一种新型吲哚甘氨酸衍生物的合成方法
JP2020500020A (ja) 2016-11-14 2020-01-09 ノバルティス アーゲー 融合誘導性タンパク質ｍｉｎｉｏｎに関連する組成物、方法、および治療上の使用
MX2019005621A (es) 2016-11-14 2019-08-12 Novartis Ag Metodos y composiciones para el tratamiento del daño del cartilago y la artritis.
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
CA3048981A1 (en) 2016-12-30 2018-07-05 Sutrovax, Inc. Polypeptide-antigen conjugates with non-natural amino acids
US10266578B2 (en) 2017-02-08 2019-04-23 Bristol-Myers Squibb Company Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereof
US11898187B2 (en) 2017-08-15 2024-02-13 Northwestern University Protein glycosylation sites by rapid expression and characterization of N-glycosyltransferases
US11530432B2 (en) 2018-03-19 2022-12-20 Northwestern University Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
US11725224B2 (en) 2018-04-16 2023-08-15 Northwestern University Methods for co-activating in vitro non-standard amino acid (nsAA) incorporation and glycosylation in crude cell lysates
AU2019263303A1 (en) 2018-05-01 2020-12-24 Ambrx, Inc. A method for optimizing antibody expression
CA3111576A1 (en) 2018-09-11 2020-03-19 Ambrx, Inc. Interleukin-2 polypeptide conjugates and their uses
EP3867265A1 (de) 2018-10-19 2021-08-25 Ambrx, Inc. Interleukin-10 -polypeptid-konjugate, dimere davon und ihre verwendungen
KR20220151202A (ko) 2020-03-11 2022-11-14 암브룩스, 인코포레이티드 인터류킨-2 폴리펩타이드 접합체 및 그의 사용 방법

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) * 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5369017A (en) * 1994-02-04 1994-11-29 The Scripps Research Institute Process for solid phase glycopeptide synthesis
US6465612B1 (en) * 1998-09-23 2002-10-15 The Regents Of The University Of California Synthetic peptides, conjugation reagents and methods
JP2005502322A (ja) 2001-04-19 2005-01-27 ザ スクリップス リサーチ インスティテュート 非天然アミノ酸のインビボ組込み
EP2292271A3 (de) 2001-10-10 2011-09-14 BioGeneriX AG Neumodulierung und Glykokonjugation von Antikörpern
KR20050073559A (ko) * 2002-10-16 2005-07-14 더 스크립스 리서치 인스티튜트 당단백질 합성
DE60327369D1 (de) * 2002-10-16 2009-06-04 Scripps Research Inst Stellenspezifischer einbau von ketoaminosäuren in proteine
WO2004058946A2 (en) * 2002-12-22 2004-07-15 The Scripps Research Institute Protein arrays
US7618775B2 (en) * 2003-04-17 2009-11-17 The Scripps Research Institute Expanding the eukaryotic genetic code
EP1636340A4 (de) * 2003-06-18 2009-02-11 Scripps Research Inst Ergänzungen zum genetischen code von unnatürlichen reaktiven aminosäuren
PT1914314E (pt) * 2003-07-07 2010-09-08 Scripps Research Inst Composições de pares ortogonais de lisil-arnt e aminoacil-arnt-sintetase e suas utilizações
EP1658366A4 (de) * 2003-07-07 2006-08-09 Scripps Research Inst Zusammensetzungen von orthogonalen glutamyl-trna- und aminoacyl-trna-synthetasepaaren und deren verwendungen
EP1704242A4 (de) * 2003-07-07 2008-06-18 Scripps Research Inst ZUSAMMENSETZUNGEN MIT PAAREN VON ORTHOGONALER LEUCYL-tRNA UND AMINOACYL-tRNA-SYNTHETASE UND VERWENDUNGEN DAVON
JP5657850B2 (ja) * 2003-10-14 2015-01-21 ザ スクリプス リサーチ インスティテュート 酸化還元機能性アミノ酸のタンパク質への部位特異的組み入れ
AU2004321117B2 (en) * 2003-12-18 2010-09-02 The Scripps Research Institute Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
BRPI0511482A (pt) * 2004-05-25 2007-12-26 Scripps Research Inst incorporação sìtio-especìfica de aminoácidos artificiais contendo átomos pesados em proteìnas para determinação de estrutura cristalina
WO2006034410A2 (en) * 2004-09-21 2006-03-30 The Scripps Resarch Institute Adding photoregulated amino acids to the genetic code
US7718410B2 (en) * 2004-09-21 2010-05-18 The Scripps Research Institute In vivo incorporation of alkynyl amino acids into proteins in eubacteria
WO2006036779A2 (en) * 2004-09-22 2006-04-06 The Scripps Research Institute Site-specific labeling of proteins for nmr studies
US20080064059A1 (en) * 2004-10-20 2008-03-13 Scripps Research Institute In Vivo Site-Specific Incorporation of N-Acetyl-Galactosamine Amino Acids in Eubacteria
BRPI0517381A (pt) * 2004-10-27 2008-10-07 Scripps Research Inst componentes ortogonais de tradução para a incorporação in vivo de aminoácidos não naturais
KR20080069993A (ko) * 2005-10-12 2008-07-29 더 스크립스 리서치 인스티튜트 파지-디스플레이된 폴리펩티드의 선별적인 번역후 변형
JP5589186B2 (ja) * 2006-03-09 2014-09-17 ザ スクリプス リサーチ インスティテュート 真正細菌宿主細胞における直交翻訳成分の発現システム
US8217145B2 (en) * 2006-03-16 2012-07-10 The Scrips Research Institute Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
WO2007139870A1 (en) * 2006-05-23 2007-12-06 The Scripps Research Institute Genetically encoded fluorescent coumarin amino acids
MX2009002987A (es) * 2006-09-21 2009-04-28 Scripps Research Inst Expresion geneticamente programada de proteinas selectivamente sulfatadas en eubacterias.
JP2010506591A (ja) * 2006-10-18 2010-03-04 ザ スクリップス リサーチ インスティテュート 哺乳動物細胞中の蛋白質への非天然アミノ酸の遺伝的組込み
US20090197339A1 (en) * 2008-12-10 2009-08-06 The Scripps Research Institute In vivo unnatural amino acid expression in the methylotrophic yeast pichia pastoris

Also Published As

Publication number Publication date
IL196909A0 (en) 2011-07-31
IL196906A0 (en) 2011-07-31
US20050233412A1 (en) 2005-10-20
US20050266526A1 (en) 2005-12-01
ATE445709T1 (de) 2009-10-15
US7825226B2 (en) 2010-11-02
US20050209133A1 (en) 2005-09-22
US20050186656A1 (en) 2005-08-25
US6927042B2 (en) 2005-08-09
ES2333422T3 (es) 2010-02-22
HK1074855A1 (en) 2006-01-13
SG160203A1 (en) 2010-04-29
IL196904A0 (en) 2011-07-31
CA2500653A1 (en) 2004-04-29
US7560535B2 (en) 2009-07-14
IL196905A0 (en) 2011-07-31
US20050186657A1 (en) 2005-08-25
US7262040B2 (en) 2007-08-28
IL196905A (en) 2012-08-30
US7217809B2 (en) 2007-05-15
US7834159B2 (en) 2010-11-16
US20040138106A1 (en) 2004-07-15
US7129333B2 (en) 2006-10-31
EP1558747B1 (de) 2009-10-14
JP4752001B2 (ja) 2011-08-17
EP1558747A2 (de) 2005-08-03
US20050181471A1 (en) 2005-08-18
US7238510B2 (en) 2007-07-03
MXPA05003978A (es) 2005-06-22
EP1558747A4 (de) 2007-07-18
AU2003286436B2 (en) 2010-08-19
US20070172915A1 (en) 2007-07-26
US20070184517A1 (en) 2007-08-09
AU2003286436A1 (en) 2004-05-04
US20100009425A1 (en) 2010-01-14
WO2004035605A3 (en) 2005-05-12
US7183082B2 (en) 2007-02-27
KR20050073559A (ko) 2005-07-14
JP2006507358A (ja) 2006-03-02
IL196907A0 (en) 2011-07-31
US7199222B2 (en) 2007-04-03
US20080213828A1 (en) 2008-09-04
IL196908A0 (en) 2011-07-31
WO2004035605A2 (en) 2004-04-29

Similar Documents

Publication Publication Date Title
DE60329700D1 (en) Glycoproteinsynthese
WO2006045116A3 (en) In vivo site-specific incorporation of n-acetyl-galactosamine amino acids in eubacteria
WO2007120932A3 (en) Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
IL196893A (en) Cell or cell line of vertebrate-containing amino acids trna synthase
SG158172A1 (en) An implantable biomaterial and a method of producing same
DK1438321T3 (da) Modificeret L-nukleinsyre
SI1966240T1 (sl) Laktoferinski peptidi, uporabni kot celico penetrirajoči peptidi
WO2007047829A3 (en) Novel heterodimeric proteins and uses thereof
WO2001014569A3 (de) Erhöhung des polysaccharidgehaltes in pflanzen
TW200616289A (en) Patch panel system
WO2007061631A8 (en) Production of glycoproteins with reduced o-glycosylation
AU2003264746A1 (en) Single-molecule in vitro evolution
WO2006019876A3 (en) Production of fusion proteins by cell-free protein synthesis
PL1817330T3 (pl) Pochodne alergenów białkowych
TW200724112A (en) Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
GB0208041D0 (en) Method of culturing animal cells
DE60314491D1 (de) Hefe-Extraktlösung, ihre Herstellung und Verwendung zur zellfreien Proteinsynthese
IL162343A0 (en) Cell constructs cultured in vitro, preparation anduses
PT1276763E (pt) Proteinas anti-congelantes sua producao e utilizacao
EP1641813A4 (de) Verfahren zur herstellung von molekülen mit verminderter immunogenität
WO2004072262A3 (en) Cultured cd14+ antigen presenting cells
WO2002094992A3 (en) Directed evolution of protein in mammalian cells
ATE329600T1 (de) Verwendung von tagatose zur verbesserung wichtiger blutfaktoren
AU2002365217A1 (en) Multi-disciplinary approach to validating or identifying targets using an in vivo system
WO2006029130A3 (en) Methods of identifying tumor associated glycoproteins

Legal Events

Date Code Title Description
8364 No opposition during term of opposition